Correlation Between Rakovina Therapeutics and Infrastructure Dividend

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rakovina Therapeutics and Infrastructure Dividend at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rakovina Therapeutics and Infrastructure Dividend into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rakovina Therapeutics and Infrastructure Dividend Split, you can compare the effects of market volatilities on Rakovina Therapeutics and Infrastructure Dividend and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rakovina Therapeutics with a short position of Infrastructure Dividend. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rakovina Therapeutics and Infrastructure Dividend.

Diversification Opportunities for Rakovina Therapeutics and Infrastructure Dividend

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Rakovina and Infrastructure is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Rakovina Therapeutics and Infrastructure Dividend Split in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Infrastructure Dividend and Rakovina Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rakovina Therapeutics are associated (or correlated) with Infrastructure Dividend. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Infrastructure Dividend has no effect on the direction of Rakovina Therapeutics i.e., Rakovina Therapeutics and Infrastructure Dividend go up and down completely randomly.

Pair Corralation between Rakovina Therapeutics and Infrastructure Dividend

Assuming the 90 days horizon Rakovina Therapeutics is expected to generate 9.57 times more return on investment than Infrastructure Dividend. However, Rakovina Therapeutics is 9.57 times more volatile than Infrastructure Dividend Split. It trades about 0.1 of its potential returns per unit of risk. Infrastructure Dividend Split is currently generating about 0.32 per unit of risk. If you would invest  50.00  in Rakovina Therapeutics on April 23, 2025 and sell it today you would earn a total of  18.00  from holding Rakovina Therapeutics or generate 36.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Rakovina Therapeutics  vs.  Infrastructure Dividend Split

 Performance 
       Timeline  
Rakovina Therapeutics 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Rakovina Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Rakovina Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Infrastructure Dividend 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Infrastructure Dividend Split are ranked lower than 25 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Infrastructure Dividend displayed solid returns over the last few months and may actually be approaching a breakup point.

Rakovina Therapeutics and Infrastructure Dividend Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rakovina Therapeutics and Infrastructure Dividend

The main advantage of trading using opposite Rakovina Therapeutics and Infrastructure Dividend positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rakovina Therapeutics position performs unexpectedly, Infrastructure Dividend can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Infrastructure Dividend will offset losses from the drop in Infrastructure Dividend's long position.
The idea behind Rakovina Therapeutics and Infrastructure Dividend Split pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes